Clinical Trials Directory

Trials / Terminated

TerminatedNCT02783157

Transcutaneous Autonomic Modulation in Thoracic Surgery

Transcutaneous Autonomic Modulation to Prevent Organ Injury After Thoracic Surgery

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
2 (actual)
Sponsor
Duke University · Academic / Other
Sex
All
Age
40 Years – 90 Years
Healthy volunteers
Not accepted

Summary

In this study, the investigators aim to determine whether non-invasive autonomic modulation decreases inflammation and complications after thoracic surgery. The investigators will test the hypothesis that low-level transcutaneous vagal nerve stimulation (LLVNS) during major thoracic surgery reduces inflammation and complications, particularly postoperative atrial fibrillation (POAF). This will be a prospective randomized pilot trial of 200 patients undergoing major thoracic surgery including lobectomy, bilobectomy, or pneumonectomy via either video-assisted thoracoscopic (VAT) or open thoracotomy. Patients will be randomized to receive ether a) LLVNS (n=100) or b) sham LLVNS (n=100) during their procedure. All patients will receive standardized anesthetic, surgical, and post-surgical care. The primary outcome in this study will be time to occurrence of in-hospital POAF, which will be compared between groups using Cox proportional hazards models. Secondary outcomes will be ICU and hospital length of stay, postoperative morbidity, postoperative mortality, and serologic markers of inflammation.

Conditions

Interventions

TypeNameDescription
DEVICETranscutaneous Low-Level Vagal Nerve Stimulation (LLVNS)Low-level vagal nerve stimulation will be delivered via a clip applied to the ear throughout the surgical procedure. The voltage used will be individualized to each patient, based upon the voltage necessary to slow the sinus rate during testing.
DEVICESham LLVNSA clip will be applied to the ear, but no stimulation will be delivered throughout the procedure.

Timeline

Start date
2016-05-01
Primary completion
2020-02-21
Completion
2020-02-21
First posted
2016-05-26
Last updated
2020-04-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02783157. Inclusion in this directory is not an endorsement.